Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81
Document › Details

Thermo Fisher Scientific Inc.. (10/18/10). "Press Release: Thermo Fisher Forms Scientific Advisory Board. Experts in Scientific Research to Provide Insight on Future Product Development". Waltham, MA.

Organisations Organisation Thermo Fisher Scientific Inc. (NYSE: TMO)
  Group Thermo Fisher (Group)
  Organisation 2 MIT (Massachusetts Institute of Technology)
Products Product analytical instrument
  Product 2 BIOTECH
Persons Person Casper, Marc N. (Thermo Fisher 200910– CEO before 200805– COO joined Thermo 12/01 before Kendro CEO before Dade Behring)
  Person 2 Gygi, Steven (Harvard Univ 201003 Associate Professor Harvard Medical School)

Thermo Fisher Scientific Inc. (NYSE:TMO), the world leader in serving science, today announced that it has formed a Scientific Advisory Board to formalize the two-way exchange of technological information between the company and representatives from some of the world's premiere centers of health, science and education.

"Scientific discovery is often the catalyst for change," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific. "The insight and distinct expertise of each member of our Scientific Advisory Board will be invaluable in helping us set a course for the innovation of new products and services that will meet the changing needs of our customers."

At the Scientific Advisory Board's inaugural meeting held recently, Mr. Casper was joined by Thermo Fisher board member Tyler Jacks, Ph.D., David H. Koch Professor of Biology at the Massachusetts Institute of Technology (MIT) and director of the David H. Koch Institute for Integrative Cancer Research, and R&D leaders representing the company's key growth platforms. External members of the Scientific Advisory Board, in addition to Dr. Jacks, are renowned researchers Ronald W. Davis, Stanford University, Department of Biochemistry; Steven P. Gygi, Ph.D., Harvard Medical School, Department of Cell Biology; William C. Hahn, M.D., Ph.D., Dana-Farber Cancer Institute, Department of Medical Oncology and David R. Hillyard, M.D., University of Utah, Department of Pathology.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science. Our mission is to enable our customers to make the world healthier, cleaner and safer. With revenues of more than $10 billion, we have approximately 35,000 employees and serve customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as in environmental and process control industries. We create value for our key stakeholders through two premier brands, Thermo Scientific and Fisher Scientific, which offer a unique combination of continuous technology development and the most convenient purchasing options. Our products and services help accelerate the pace of scientific discovery, and solve analytical challenges ranging from complex research to routine testing to field applications. Visit

Thermo Fisher Scientific Inc.

Media Contact Information:
Ron O'Brien, 781-622-1242
Investor Contact Information:
Ken Apicerno, 781-622-1294

Record changed: 2016-03-19


Picture EBD Group BIO-Europe 2020 Digital Event BEU2020 650x81

More documents for Thermo Fisher (Group)

To subscribe to our free, monthly mass spectrometry newsletter, please send an e-mail to and simply fill the subject line with the word »MSC Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the Eurpean life sciences and the life sciences in German-speaking Europe (DE, AT & CH) at and


Picture [iito] Fighting Customers 650x80px

» top